Post-hoc analyses of a large, randomized clinical trial have revealed the potential advantages associated with electronic informed consent (eConsent) in acute ischemic stroke studies, including increased enrollment rates and improved adherence to consent documentation.
This article was originally published on MedicalXpress.com